International Pharmacy Debate: Pharmacogenomics is Over-Rated
WebinarMembers are invited to join an exciting international pharmacy debate: "Pharmacogenomics is Over-Rated” presented in collaboration with the Canadian Association of Pharmacy in Oncology (CAPhO), International Society of Oncology Pharmacy Practitioners (ISOPP), British Oncology Pharmacists Association (BOPA), and the Clinical Oncology Society of Australia – Clinical Pharmacists Group (COSA CPG).
Format: Fast-paced, 3-minute-thesis style presentations with evidence, energy, and a touch of humour
Expect: Lively arguments, rapid-fire rebuttals, and global perspectives.
Why this debate? Pharmacogenomics (PGx) is increasingly recognised for its role in personalising care and improving patient outcomes. But is its impact overstated? This debate will bring together leading oncology pharmacy voices from CAPhO, ISOPP, BOPA, and COSA to argue both sides.
Authors/Presenters
